Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anagrelide vs hydroxyurea in essential thrombocythemia
CTR20131361Phase 3Completed
- Sponsor
- Beijing Shangdi New Century Biological Medicine Research Institute
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of anagrelide in thrombocythemia, sponsored by Beijing Shangdi New Century Biological Medicine Research Institute. Started Nov 2014; status: completed.
02
Drugs
anagrelide
03
Conditions
thrombocythemia
Beyond the preview
Go deeper on CTR20131361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131361.